Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Stroke. 2018 Aug;49(8):1981–1984. doi: 10.1161/STROKEAHA.118.022133

Table 1.

Patient demographics in the two time periods.

Variable* Acute Period (hours 2–24, n=913) Subacute Period (days 2–7, n=877)
Age 62.1±13.1 61.9±12.9
Male 563 (61.7) 541 (61.7)
Asian 534 (58.4) 539 (61.5)
Glasgow Coma Score 13.7±2.1 13.7±2.1
NIH Stroke Scale 11.5±6.7 11.6±6.7
Intensive SBP control randomization arm 452 (49.5) 442 (50.4)
Prior stroke 147 (16.1) 140 (16.0)
Coronary artery disease 40 (4.4) 37 (4.2)
Antihypertensive medication* 448 (49.1) 420 (47.9)
Diabetic medication* 132 (14.5) 123 (14.0)
Minutes from ICH onset to randomization 184.0±56.8 182.5±56.2
Right-sided ICH** 475 (52.0) 455 (51.9)
Lobar ICH** 105 (11.5) 95 (10.8)
Intraventricular extension of ICH** 244 (26.7) 233 (26.6)
ICH volume (mL)** 15.1±14.8 15.2±14.3
Cerebral edema volume (mL)** 2.8±3.7 2.8±3.6
Septum pellucidum shift (mm)** 1.4±1.9 1.4±1.9
Number of blood pressure readings 46±1 12±0
Systolic mean (mm Hg) 140.2±13.5 144.0±10.8
Systolic SD (mm Hg) 14.5±5.3 22.7±8.3
Systolic CV (mm Hg) 10.3±3.6 15.8±5.8
Systolic ARV (mm Hg) 13.9±6.7 26.0±11.4
Systolic SV (mm Hg) 18.0±8.2 31.6±13.2
Systolic RSD (mm Hg) 13.9±5.3 22.3±8.9

Continuous variables: mean±SD; categorical data: n(%).

*

Pre-morbid

**

Pre-randomization CT